Cargando…

Insertion of a Synthetic Switch Into Insulin Provides Metabolite-Dependent Regulation of Hormone-Receptor Activation

Insulin signaling requires conformational change: whereas the free hormone and its receptor each adopt autoinhibited conformations, their binding leads to large-scale structural reorganization. To test the coupling between insulin’s “opening” and receptor activation, we inserted an artificial ligand...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yen-Shan, Gleaton, Jeremy, Yang, Yanwu, Dhayalan, Balamurugan, Phillips, Nelson B, Liu, Yule, Broadwater, Laurie, Jarosinski, Mark, Chatterjee, Deepak, Lawrence, Michael C, Hattier, Thomas, Michael, Dodson M, Weiss, Michael Aaron
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090162/ http://dx.doi.org/10.1210/jendso/bvab048.899

Ejemplares similares

MON-146 Prolonged Hypoglycemia in the Setting of Synthetic Cathinone Abuse
por: Ramirez Berlioz, Ana, et al.
Publicado: (2019)

RF04 | PSUN233 Design of an Ultra-Stable Insulin/Glucagon Fusion Protein
por: Grabowski, Rachel, et al.
Publicado: (2022)

SAT-644 A Case of the Use of the Eversense Continuous Glucose Monitor with Repeated Same-Pocket Insertion
por: Lee, Warren, et al.
Publicado: (2020)

SAT-638 An Academic Center Experience with the Eversense Continuous Glucose Monitoring System and Assessment of Intrapatient Variability with Repeated Same-Pocket Insertion
por: Lee, Warren, et al.
Publicado: (2020)

SUN-143 Does a Monogenic Diabetes Diagnosis Impact Quality of Life?
por: Harris, Anastasia, et al.
Publicado: (2019)

SUN-LB119 Role of HNF4a Isoforms in the Carbohydrate/Lipid Switch in the Liver and Responsiveness to AMPK
por: Radi, Sarah, et al.
Publicado: (2020)

Yy1 Depletion in Pancreatic Beta Cells Leads to Energy Source Switch From Glycolysis to Oxidative Phosphorylation
por: Perez-Garcia, Eliana M, et al.
Publicado: (2021)

Clinical Effectiveness and Safety of Gliclazide MR and Linagliptin Combination in the Management of Patients With T2DM and Chronic Kidney Disease (CKD) Switched From Glimepiride - a Real-World, Retrospective, Observational Study
por: Bhattacharyya, Supratik, et al.
Publicado: (2021)

SAT-664 Fluctuating Blood Glucose in an Infant with Newly Diagnosed IPEX Syndrome
por: Gottesman, Bethany, et al.
Publicado: (2020)

MON-694 EDKA and MALA in the Setting of Severe Heart Failure and Acute Renal Failure, Due to SGLT2-i
por: Heckart, Jonathan Calvin, et al.
Publicado: (2020)

Virtual Patient Simulation in DKD: Successful Strategy for Improving Recognition and Management
por: Larkin, Amy, et al.
Publicado: (2021)

SAT-131 Success of CME/CE in Promoting Practice Improvements in the Use of New Technologies for Glucose Monitoring
por: Larkin, Amy, et al.
Publicado: (2019)

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

SUN-125 Role of Various Insulin Assays in the Diagnosis of Factitious Hypoglycemia
por: Balasubramanian, Priyadarshini, et al.
Publicado: (2019)

MON-LB115 Ready-To-Use Glucagon for the Prevention of Exercise-Induced Hypoglycemia in a Clinical Research Setting
por: Aronson, Ronnie, et al.
Publicado: (2020)

MON-182 Adaptable Amperometric Biosensor Platforms for the Diagnosis of Endocrine Disorders
por: Labban, Najwa, et al.
Publicado: (2019)

MON-183 Comparison of Continuous Glucose Monitor versus Meal Tolerance Test for Detection of Post-Bariatric Surgery Hypoglycemia
por: Lee, Clare, et al.
Publicado: (2019)

SAT-168 A Secreted Protein Complement 1q Like-3 Protein Inhibits Insulin Secretion by an Adhesion G-Protein Coupled Receptor, BAI3 in Pancreatic β-Cells
por: Gupta, Rajesh, et al.
Publicado: (2019)

SUN-142 High Prevalence of NAFLD and Advanced Fibrosis in Patients with Obesity and Diabetes
por: Barb, Diana, et al.
Publicado: (2019)

SUN-LB122 Sequential Testing to Assess Insulin Resistance in the Course of Participation in a Diabetes Prevention Program (DPP)
por: McPhaul, Michael John, et al.
Publicado: (2020)

The IgG Antibody Paradox in Insulin Resistance: Pathogenic and Therapeutic
por: Lipchik, Andrew, et al.
Publicado: (2021)

SUN-168 HAART-Induced Hyperglycemic Hyperosmolar Syndrome: A Rare Manifestation of HAART Therapy
por: Vora, Aarohi, et al.
Publicado: (2019)

OR05-5 AZP-3404, a 9-Amino Acid Peptide Analog of Insulin-Like Growth Factor-Binding Protein 2, Reverses Insulin Resistance in Leptin-Deficient ob/ob Mice
por: Milano, Stephane, et al.
Publicado: (2019)

OR08-06 Increased Carotid Intima Media Thickness in Pediatric Type 1 Diabetes Is Associated with Disease Duration
por: Cohen, Michal, et al.
Publicado: (2020)

OR30-01 Real-World Minimed™ 670G System Use and Glycemic Outcomes of Pediatric and Adult Individuals Living with Type 1 Diabetes (T1D) in the United States
por: Vigersky, Robert Alan, et al.
Publicado: (2020)

MON-179 Repeat BCG Vaccination Creates Lasting HbA1c Reductions in Adult Subjects with Longstanding Type 1 Diabetes by Correcting Immune-Metabolic Defects
por: Faustman, Denise, et al.
Publicado: (2019)

Type 2 Diabetes Management in Older Adults: A Personalized Approach
por: Miles, Cristy, et al.
Publicado: (2021)

OR14-3 The Association of Glycemic Control and Glycemic Variability with Treatment Patterns and Diabetes-Related Events in the Adult Patients (Pts) with Type 1 Diabetes (T1D): Results from the T1D Exchange Clinic Registry
por: Wysham, Carol, et al.
Publicado: (2019)

AZP-3404, a Peptide Analog of IGFBP-2, Induces Weight Loss and Improves Glucose Metabolism in Leptin-Resistant db/db Mice
por: Culler, Michael D, et al.
Publicado: (2021)

MON-184 Hypoglycemia During Mixed Meal Tolerance Testing and Early Glucose Dysregulation in Cystic Fibrosis
por: Kilberg, Marissa, et al.
Publicado: (2019)

SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020)

MON-LB110 A Phase 2 Evaluation of a Ready-To-Use Liquid Stable Continuous Subcutaneous Glucagon Infusion for the Treatment of Hypoglycemia Associated Autonomic Failure
por: Pettus, Jeremy H, et al.
Publicado: (2020)

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
por: Molitch, Mark, et al.
Publicado: (2019)

SUN-672 SGLT2 Inhibitor Reduces Hyperinsulinemia and Restores Pulsatile Growth Hormone Secretion in Obese MC4RKO Mice
por: Huang, Zhengxiang, et al.
Publicado: (2020)

MON-LB030 Muscle Mitochondrial Oxidative Phosphorylation Capacity and Whole Body Glucose Metabolism in Friedreich's Ataxia
por: Nguyen, Sara, et al.
Publicado: (2019)

MON-660 Hypoglycemia Following OGTT Is More Frequent and Pronounced in CF Compared with Controls
por: Harris, Clea D, et al.
Publicado: (2020)

OR26-06 Fecal Microbiota Transplantation Trial for the Improvement of Metabolism (FMT-TRIM): A Randomized Double-Blind Placebo-Controlled Pilot Trial
por: Yu, Elaine Wei-Yin, et al.
Publicado: (2020)

SAT-169 Selective Nonpeptide Somatostatin Subtype 5 (sst5) Agonists Suppress Glucose- and Sulfonylurea-Induced Insulin Secretion in Rats
por: Sturchler, Emmanuel, et al.
Publicado: (2019)

OR22-2 Exposure to Hypoglycemia in Older Adults with Type 1 Diabetes: Baseline Characteristics Using Continuous Glucose Monitoring Data
por: Carlson, Anders, et al.
Publicado: (2019)

Clinical Characteristics and Outcomes Among COVID 19 Hospitalized Patients in a Community Hospital in New York City
por: Rodriguez, Giovanna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1c4fsqju6vrfinlrqpnui5hj2n